, Volume 4, Issue 3, pp 153–161 | Cite as

Spine Abnormalities and Damage in Patients Cured from Cushing's Disease

  • Antongiulio Faggiano
  • Rosario Pivonello
  • Mariagiovanna Filippella
  • Carolina Di Somma
  • Francesco Orio Jr
  • Gaetano Lombardi
  • Annamaria Colao


The skeletal system is a common target of glucocorticoids. Structural and functional impairment of skeletal system is a relevant cause of morbidity and disability in patients with Cushing's syndrome.

Thirty-six patients long-term (3.9 ± 0.5 yrs) cured from Cushing's disease (CD), 26 with adulthood-onset CD (AOCD) and 10 with childhood-onset CD (COCD) and 2 groups of controls, 24 age- and sex-matched patients with nonfunctioning pituitary adenomas (NFA) and 36 age- and sex-matched healthy subjects (HS), entered this open transversal controlled study to evaluate the prevalence of spine abnormalities and damage by standard radiography in subjects with a history of Cushing's syndrome.

Symptoms and signs of backache were present in 86.1% CD patients (100% COCD and 80.8% AOCD), in 30.5% HS (χ2 = 20.6, p < 0.0001) and 37.5% NFA patients (χ2 = 13.2, p < 0.0001). The prevalence of trabecular bone rarefaction (χ2 = 6.5, p < 0.01 and χ2 = 4.5, p < 0.05), vertebral collapse (χ2 = 10.7, p < 0.01 and χ2 = 7.0, p < 0.01) and scoliosis (χ2 = 10.9, p < 0.01 and χ2 = 11.1, p < 0.01) resulted significantly increased in CD patients as compared both to HS and NFA patients. In CD patients, the number of collapsed vertebral bodies was significantly correlated to age of disease onset (r = −0.63, p < 0.0001), disease duration (r = 0.33, p < 0.05) and urinary free cortisol levels at disease diagnosis (r = 0.72, p < 0.0001). The prevalence of cortical bone sclerosis was significantly increased in AOCD than in HS (χ2 = 6.5, p < 0.01) and COCD (χ2 = 7.7, p < 0.01) whereas that of trabecular bone rarefaction was significantly higher in COCD patients than in HS (χ2 = 18.3, p < 0.0001), NFA (χ2 = 14.2, p < 0.0001) and AOCD patients (χ2 = 9.1, p < 0.01).

Patients cured from CD have increased prevalence of spine damage, mostly when the disease developed before the completion of skeletal growth. Therefore, a periodical radiological follow-up of the skeleton and a specific treatment for the bone damage should be included in the management of patients with Cushing's syndrome.

Cushing's disease hypercortisolism spine standard radiography skeletal abnormalities bone disease 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Aron DC, Findling JW, Tyrrel JB. Cushing's disease. Endocrinol Metab Clin North Am 1987;16:705–730.Google Scholar
  2. 2.
    Etxabe J, Vazquez JA. Morbidity and mortality in Cushing's disease: An epidemiological approach. Clin Endocrinol 1994;40:479–484.Google Scholar
  3. 3.
    Colao A, Pivonello R, Spiezia S, Faggiano A, Ferone D, Filippella M, Marzullo P, Cerbone G, Siciliani M, Lombardi G. Persistence of increased cardiovascular risk in patients with Cushing's disease after 5 years of successful cure. J Clin Endocrinol Metab 1999;84:2664–2672.Google Scholar
  4. 4.
    Murray RO. Radiological bone changes in Cushing's syndrome and steroid therapy. Br J Radiol 1959;33:1–19.Google Scholar
  5. 5.
    Lukert BP, Raisz LG. Glucocorticoid-induced osteoporosis: Pathogenesis and management.Ann Intern Med1990;112:352–364.Google Scholar
  6. 6.
    Fitzpatrick LA. Glucocorticoid-induced osteoporosis. In: Marcus R, ed. Osteoporosis. Boston: Blackwell Scientific, 1994;202–226.Google Scholar
  7. 7.
    Canalis E. Mechanisms of glucocorticoid action in bone: Implications to glucocorticoid-induced osteoporosis. J Clin Endocrinol Metab 1996;81:3441–3447.Google Scholar
  8. 8.
    Cooper MS, Hewison M, Stewart PM. Glucocorticoid activity, inactivity and the osteoblast. J Endocrinol 1999;163:159–164.Google Scholar
  9. 9.
    Maldague B, Malghem J, Nagant de Deuxchaisnes C. Radiological aspects of glucocorticoid-induced bone disease. Adv Exp Med Biol 1984;171:155–190.Google Scholar
  10. 10.
    Hermus AR, Smals AG, Swinkels LM, Huysmans DA, Pieters GF, Sweep CF, Corstens FH, Kloppenborg PW. Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome. J Clin Endocrinol Metab 1995;80:2859–2865.Google Scholar
  11. 11.
    DiSomma C, Colao A, Pivonello R, Klain M, Faggiano A, Tripodi FS, Merola B, Salvatore M, Lombardi G. Effectiveness of a chronic treatment with alendronate in the osteoporosis of Cushing's disease. Clin Endocrinol 1998;48:655–662.Google Scholar
  12. 12.
    Chew F. Radiologic manifestations in the muscoloskeletal system of miscellaneous endocrine disorders. Radiol Clin North Am 1991;29:135–147.Google Scholar
  13. 13.
    Cosman F, Nieves J, Herbert J, Shen V, Lindsay R. Highdose glucocorticoids in multiple sclerosis patients exert direct effects on the kidney and skeleton. J Bone Miner Res 1994;9:1097–1105.Google Scholar
  14. 14.
    Lebrethon MC, Grossman AB, Afshar F, Plowman PN, Besser GM, Savage MO. Linear growth and final height after treatment for Cushing's disease in childhood. J Clin Endocrinol Metab 2000;85:3262–3265.Google Scholar
  15. 15.
    Xiong B, Sevastik JA, Hedlund R, Sevastik B. Radiographic changes at the coronal plane in early scoliosis. Spine 1994;19:159–164.Google Scholar
  16. 16.
    Shirazi-Adl A, Parnianpour M. Effect of changes in lordosis on mechanisms of the lumbar spine-lumbar curvature in lifting. J Spinal Disord 1999;12:436–447.Google Scholar
  17. 17.
    Guglielmi G, De Serio A, Leone A, Agrori L, Cammina M. Imaging in degenerative disease of the lumbar spine. Rays 2000;25:19–33.Google Scholar
  18. 18.
    Cushing H. Basophil adenoma of the pituitary body and their clinical manifestations. Bull Johns Hopkins Hosp 1932;50:137–195.Google Scholar
  19. 19.
    Manning P, Evans M, Reid I. Normal bone mineral density following cure of Cushing's syndrome. Clin Endocrinol 1992;36:229–234.Google Scholar
  20. 20.
    Ruegsegger P, Medici T, Anliker M. Corticosteroid-induced bone loss: A longitudinal study of alternate day therapy in patients with bronchial asthma using quantitative computed tomography. Eur J Clin Pharmacol 1983;25:615–620.Google Scholar
  21. 21.
    Magiakou MA, Mastorakos G, Gomez MT, Rose SR, Chrousos GP. Suppressed spontaneous and stimulated growth hormone secretion in patients with Cushing's disease before and after surgical cure. J Clin Endocrinol Metab 1994;78:131–137.Google Scholar
  22. 22.
    Turner RT, Riggs BL, Spelsberg TC. Skeletal effects of estrogen. Endocr Rev 1994;15:275–300.Google Scholar
  23. 23.
    Thevenon A, Pollez B, Cantergrit F, Tison-Muchery F, Marchandise X, Duquesnoy B. Relationship between kyphosis, scoliosis and osteoporosis in the elderly population. Spine 1987;12:744–745.Google Scholar
  24. 24.
    Allen DB, Goldberg BD. Stimulation of collagen synthesis and linear growth in glucocorticoid-treated children. Pediatrics 1992;89:416–421.Google Scholar
  25. 25.
    Higuchi M, Abe K. Effects of hydrocortisone on the vertebral cartilage plate in mice. A light and electron microscopic study. Spine 1985;10:297–302.Google Scholar

Copyright information

© Kluwer Academic Publishers 2001

Authors and Affiliations

  • Antongiulio Faggiano
    • 1
  • Rosario Pivonello
    • 1
  • Mariagiovanna Filippella
    • 1
  • Carolina Di Somma
    • 1
  • Francesco Orio Jr
    • 1
  • Gaetano Lombardi
    • 1
  • Annamaria Colao
    • 1
  1. 1.Department of Molecular and Clinical Endocrinology and Oncology“Federico II” UniversityNaplesItaly

Personalised recommendations